PMV Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
PMVP
CUSIP
69353Y103
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 69353Y103 since 12/18/2024, largest first.

Filer % of Class Filed
Tang Capital Management LLC 13G/A
10.0% 11/16/2026
Event 9/30/2026
Samsara BioCapital, L.P. 13G
9.9% 9/15/2026
Event 9/2/2026
BML Investment Partners, L.P. 13G/A 9.9% 2/9/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Sio Capital Management, LLC 13G/A 4.9% 7/28/2026
Event 6/30/2026
Euclidean Capital LLC 13G/A
4.9% 5/15/2026
Event 3/31/2026
ArrowMark Colorado Holdings LLC 13G/A 3.7% 7/10/2026
Event 6/30/2026
Orbimed Advisors LLC 13D/A
0% 3/4/2026
Event 3/2/2026
PFM Health Sciences, LP 13G/A
0% 8/14/2025
Event 6/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 65 56.5 M $94.4M
2026 Q2 64 34.3 M $45.9M
2026 Q1 69 37.0 M $45.8M
2025 Q4 65 37.4 M $46.8M
2025 Q3 64 37.5 M $52.5M
2025 Q2 55 34.7 M $36.8M
2025 Q1 56 37.3 M $40.7M
2024 Q4 71 39.0 M $58.8M
2024 Q3 75 39.0 M $58.2M
2024 Q2 94 40.5 M $65.6M
2024 Q1 100 42.7 M $72.7M
2023 Q4 100 46.5 M $144M
2023 Q3 107 54.2 M $333M
2023 Q2 107 51.8 M $324M
2023 Q1 113 51.5 M $246M
2022 Q4 116 54.5 M $474M
2022 Q3 122 58.2 M $692M
2022 Q2 109 61.1 M $871M
2022 Q1 106 55.2 M $1.15B
2021 Q4 107 47.5 M $1.10B
2021 Q3 93 44.0 M $1.31B
2021 Q2 88 42.2 M $1.44B
2021 Q1 82 39.9 M $1.31B
2020 Q4 74 38.2 M $2.34B
2020 Q3 52 31.2 M $1.10B